Deletion or mutations in TNFAIP3 on 6q23 are commonly found in DLBCL and WM10,11, and when combined with a MYD88 mutation may further lead to deregulated NF-κB activation. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.